InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: mikar post# 10939

Monday, 10/11/2021 10:35:20 AM

Monday, October 11, 2021 10:35:20 AM

Post# of 13742
I don't think it will hit a dollar until after QNTA gets the approval for the IND application which should be sooner than later.

There will always be runs however for QNTA to have a sustained upward movement it will take consistent solid results. They have built a great brand and have a solid footing in moving through the FDA bureaucracy.

QNTA built it and I'm hopeful results will come.


There is no reason for the stock price to increase significantly at this point in time.

QNTA has a lot of things going on and until we see some results such as increased product sales or FDA approvals, the stock price will suffer.

ESCOZINE:

It is on a road trip with down the FDA freeway with detours along the way. However QNTA will reach their intended destination which is IND application approval.


Detour

Subsequent to the acknowledgement of the trial, the FDA has requested that the Company complete two additional toxicology studies in animals. Since adoption of COVID-19 vaccinations, the FDA altered its protocol for measuring toxicology to include studying it at the DNA level. As this is a newer development, the agency has asked Medolife to provide data in this regard. Medolife has the product and protocol necessary to complete these studies in short-order.


Will there be more detours?


We will find out after QNTA submits the two addition toxicology studies.

We have people in our camp that should help to get us through the FDA approval process:

“Given the ever-changing landscape of COVID-19, we are pleased that the FDA recognizes that our original proposed study was a proof-of-concept design under our original Pre-IND submission,” said Christina DiArcangelo, CEO and Founder of Affinity Bio Partners, a contracted clinical consultant for Medolife.



DiArcangelo has 24 years of experience in the global biotechnology, pharmaceutical, device, and nutraceutical industries and has worked on products that have received FDA approval on 25 pharmaceutical drugs.


Also there are many other products that are coming into the fold.

Breakout imminent!!!


https://finance.yahoo.com/quote/QNTA/history?p=QNTA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.